No Data
No Data
GRI Bio Receives Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in Australia
GRI Bio Participates in Virtual Investor KOL Connect Segment
Express News | GRI Bio : Received Nasdaq Notice for Minimum Bid Price Non-Compliance
GRI Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference
GRI Bio to Present at the 2024 European Respiratory Congress
GRI Bio Reports Q2 Results
No Data
No Data